Chapter I
What is known about possible harm?
It is reasonable to ask what could go wrong, how much is known and who will help if a problem arises.
What the older reports can tell you
A review found the most common side effects in older sermorelin studies were brief face redness or warmth and pain where a shot was given.
Those reports came largely from children’s studies and do not give current adult side-effect rates.
Sermorelin lacks a current drug information sheet reviewed by FDA that sets out warnings or information on pregnancy use, as of September 28, 2026.
This means an official information sheet, not the sticker on your bottle. Ask the person assessing you how these gaps relate to your own health history.
Ask about the hormone-related concerns
Growth hormone is a body signal that helps children grow; raising its level can also bring concerns for adults.
FDA reviews of related drugs describe possible concerns from higher growth-hormone levels.
Raised blood sugar and the body holding extra water are among those concerns.
Those reviews discuss related peptides, rather than an FDA assessment of sermorelin for adults.
Ask which concerns matter to the proposed plan and what would be checked along the way.
How it is made also matters
FDA says errors in compounding can contaminate medicine or put the amount of its active ingredient above or below what it should be.
A drug’s active ingredient is what is meant to produce its effect.
FDA does not review a compounded product’s safety, quality or effectiveness before it reaches the market, as of September 26, 2026.
Return to the pharmacy checkWhen urgent help matters
MedlinePlus was checked September 17, 2026: it says a severe allergic reaction needs emergency help and may start in seconds or minutes.
MedlinePlus advises an emergency call for severe symptoms such as breathing difficulty or swelling of your tongue or face; dial 911 or your area’s emergency number.
These signs call for urgent help; you do not need to work out the cause yourself.